A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients
Clinical trial NCT04581343 · COMPLETED
Trial details
- NCT number
- NCT04581343
- Sponsor
- Pancreatic Cancer Action Network
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2022-11-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.